The report will provide an outline of the global pharmaceutical industry and an ESG overview of the pharmaceutical industry. Qualitative insights on ESG trends and their impact on pharmaceutical manufacturers are provided, along with a detailed analysis of the pharmaceutical industry supply chain with regard to ESG. The report explains the primary drivers, challenges and trends influencing ESG implementation in the pharmaceutical industry.
- A brief general outlook of the ESG trends in pharmaceutical industry
- Detailed information about ESG-related developments in the pharmaceutical industry and analyses of factors affecting ESG applications
- Discussion of current trends and issues in the pharmaceutical industry, with emphasis on major challenges and opportunities
- Analysis of the whole supply chain of the pharmaceutical industry and its association with ESG
- Information on major causes, and impact of pharmaceutical pollution and a detailed case study related to pharmaceutical pollution